Cargando…
Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period?
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319216/ https://www.ncbi.nlm.nih.gov/pubmed/32838149 http://dx.doi.org/10.1007/s42399-020-00375-0 |
_version_ | 1783551011043934208 |
---|---|
author | Ferrara, Francesco De Rosa, Francesco Vitiello, Antonio |
author_facet | Ferrara, Francesco De Rosa, Francesco Vitiello, Antonio |
author_sort | Ferrara, Francesco |
collection | PubMed |
description | |
format | Online Article Text |
id | pubmed-7319216 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Springer International Publishing |
record_format | MEDLINE/PubMed |
spelling | pubmed-73192162020-06-29 Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period? Ferrara, Francesco De Rosa, Francesco Vitiello, Antonio SN Compr Clin Med Covid-19 Springer International Publishing 2020-06-26 2020 /pmc/articles/PMC7319216/ /pubmed/32838149 http://dx.doi.org/10.1007/s42399-020-00375-0 Text en © Springer Nature Switzerland AG 2020 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Covid-19 Ferrara, Francesco De Rosa, Francesco Vitiello, Antonio Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period? |
title | Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period? |
title_full | Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period? |
title_fullStr | Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period? |
title_full_unstemmed | Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period? |
title_short | Worldwide Recommendations and Therapies for Multiple Sclerosis: Are They Safe in the COVID-19 Pandemic Period? |
title_sort | worldwide recommendations and therapies for multiple sclerosis: are they safe in the covid-19 pandemic period? |
topic | Covid-19 |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7319216/ https://www.ncbi.nlm.nih.gov/pubmed/32838149 http://dx.doi.org/10.1007/s42399-020-00375-0 |
work_keys_str_mv | AT ferrarafrancesco worldwiderecommendationsandtherapiesformultiplesclerosisaretheysafeinthecovid19pandemicperiod AT derosafrancesco worldwiderecommendationsandtherapiesformultiplesclerosisaretheysafeinthecovid19pandemicperiod AT vitielloantonio worldwiderecommendationsandtherapiesformultiplesclerosisaretheysafeinthecovid19pandemicperiod |